I usually stray away from bio/biotech b/c of how volatile it is, but EBS seems to be established with a 800M+ market cap, strong historicals, 20 PE ratio, and seems to be getting close to bottom. They also have an exciting narcan nasal spray product that can be sold over the counter they are working on releasing in 2023. Very relevant with all the overdoses going on in the US.
Loading up more at $11.60 and $10.69. Current avg share price for me is $12.37. Narcan drug did get FDA approved for over the counter sales. Should be up trend from here, with a few small short term bull backs.